Diabetes treatment, Adlyxin, receives FDA approval
by Press Release from Outbreak News Today on (#1NRAW)
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with type 2 diabetes. "The FDA continues to support the development of new drug therapies for diabetes management," said Mary Thanh Hai Parks, M.D., deputy director, Office of Drug ["]
